Blog

 {Photo credit: MSH staff}Amina is one of 3 million children in the Sahel region of sub-Saharan Africa who received seasonal malaria chemoprevention malaria in 2015.Photo credit: MSH staff

Four-year-old Amina is why I work on malaria. I met her in Basse District, The Gambia, last year when I was visiting the team distributing lifesaving malaria treatment to children under five. Words can’t describe the feeling of seeing this young Gambian girl, who had been severely ill with malaria, now beaming with joy, literally running to me for her fourth treatment.

Her mother walked up and described to me how sick Amina had been before MSH and partners began ensuring access to the quality-assured malaria treatments for children under five in the district. Since she first got malaria as an infant, every year during the rainy season (from September through December), Amina would become severely ill with malaria. She couldn’t play with the other kids outside, or go to school. One year, she fell into a coma and was hospitalized. But, in 2015, Amina experienced the opportunity for a healthy life: since September, she had received monthly treatment for malaria, known as seasonal malaria chemoprevention (or SMC). At four years old, Amina knew that this was what stopped her from feeling so ill, and enabled her to feel well.

She ran towards me for her medication, smiling ear to ear.

 {Photo by Catherine Lalonde/MSH}Youth in Mali, with support from Family Care International, performed plays to tell the stories of persons living with HIV/AIDS.Photo by Catherine Lalonde/MSH

“In 509 days, my country will go to the ballot box, and I will be running for office in Kenya,” announced Stephanie Musho, a law student and staffer at a global health non-profit. Musho made this bold statement while speaking on a panel of young African women leaders during the 60th session of the Commission on the Status of Women (CSW) in March.

“But first, I have to tell you a story about what it means to be a woman candidate,” she sighed. “I’ve worked hard for my campaign. I’ve met with constituents and partners to get their support and raise money. I approached two potential contributors, who were men, and they said ‘With a body like that, you shouldn’t have any problem raising money.’ I knew what they were insinuating, and I can’t believe this is still happening. But I’m not going to let that stop me.”

Musho was one of fifteen advocates from the Moremi Initiative, a women’s leadership institute in Ghana, sharing personal stories of working to effect change in their communities and for the women in their countries. Their stories provided poignant context for the challenges they faced and the triumphs they experienced.

 {Photo credit: Alan Levine via Flickr / CC BY}Vials of insulin. Diabetes medicines and health technologies, including lifesaving insulin, are available in only one in three of the world’s poorest countries.Photo credit: Alan Levine via Flickr / CC BY

Cross-posted with permission from Devex.com.

The World Health Organization’s first global report on diabetes released this month highlights the disease’s “alarming surge” with rates that have quadrupled in fewer than three decades. The report reminds us that essential diabetes medicines and health technologies, including lifesaving insulin, are available in only one in three of the world’s poorest countries.

Availability of medicines is certainly an important piece of the complex challenge of ensuring that health systems seamlessly integrate prevention, screening, referral, treatment, and adherence. However, choosing the best way to spend limited public health budgets amid competing priorities is equally important.

 {Photo credit: Ghaffar Rabiu}Dr. Zipporah Kpamor, Country Director, MSH Nigeria, is interviewed at the 10th anniversary event.Photo credit: Ghaffar Rabiu

Management Sciences for Health (MSH) celebrated 10 Years of Improving the Health of Women and Children in Nigeria with 250 stakeholders and supporters at a special event in Abuja on March 31, 2016. Distinguished guests included the chairman of the Nigerian House of Representatives, director of the Federal Ministry of Health in Nigeria, high-level representatives from state governments and partner organizations, and more.

After a rousing rendition of “Arise, Oh Compatriots,” the Nigerian national anthem, Country Director, Dr. Zipporah Kpamor, welcomed participants and underscored the intention for the day’s two round-table panel discussions:

In Nigeria, 150 women and 2,300 children die every day from preventable causes. One in five children won’t live to see their fifth birthday. This event can help continue conversations on what we can do to end preventable deaths among women, children, and young people.

Currently, MSH’s partnerships for health system strengthening in Nigeria reach nearly 560,000 people through four projects.

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

Today, April 7, we celebrate World Health Day, started by the World Health Organization (WHO) to mark its founding in 1948.

Amid Ebola, Zika, maternal and child mortality, and other global health challenges, WHO chose diabetes, for the first time, as its World Health Day theme (“Stay super. Beat diabetes”).  To urge global action on the rising diabetes burden, WHO released a new global report yesterday, April 6, highlighting key global diabetes findings, country profiles, and recommendations to reach the Sustainable Development Goal (SDG) target 3.4, which calls on countries to reduce premature death from noncommunicable diseases (NCDs), including diabetes, by 30 percent by 2030. 

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

"Medicines are a key component of treatments to save lives"

~ Kwesi Eghan, trained Ghanian pharmacist and MSH portfolio manager for the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program in South Sudan and Afghanistan

A child in Tanzania has a fever for three days. A pregnant woman in Namibia is taking antiretroviral therapy (ART) to treat HIV and prevent transmission of HIV to her baby. A man in Swaziland suffers from drug-resistant TB and struggles to adhere to treatment.

Who helps ensure they take the right drug, at the right time, and for the right reason?

A pharmacist.

In many developing countries, pharmacists are primarily responsible for medicines selection, procurement, distribution, and explaining rational use of these medicines to their patients. But, many low- and middle-income countries suffer shortages of trained pharmacists. MSH and partners are helping countries and communities ensure that pharmacists and related health workers are equipped with the skills, systems, and support to provide quality services every day.

{Photo credit: Mark Tuschman}Photo credit: Mark Tuschman

A woman. A newborn. A child. In many countries, their basic health and rights are tenuous. These women, newborns, and children are the health system.

A woman is ostracized: abandoned by her husband, her family, and her community. She suffered a fistula after giving birth to her son. After 20-plus years, an operation repairs her fistula; now, she is teaching again, and a part of the community.

{Photo credit: Mark Tuschman}Photo credit: Mark Tuschman

Impact. Scale. Sustainability. As public health professionals, we are dedicated to high-impact and high-coverage interventions that significantly improve the health of large human populations. We also hope that the benefits become part of the timeless fabric of their families, communities, and the health system.

This triple expectation—impact, scale, and sustainability—has accompanied global health for decades and especially during the last  generation. In 1990, Dr. Thomas Bossert reported that, among five US government-funded health programs in Africa and Central America, a project’s capacity to show results was the most important factor to ensure the sustainability of its benefits.

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

Tuberculosis (TB) claims a life every 15 seconds; it is the single largest infectious killer and is universally recognized as a global epidemic. Nearly 200 children die every day of TB.

The challenges of tackling TB are well known, particularly in settings with limited resources, crowded urban environments, and among high risk groups including people living with HIV, prisoners, and children. The emergence of multidrug resistant strains of the disease (MDR-TB), the result of incomplete or poor managed TB treatment, present further obstacles and add exponential costs to already burdened health systems. Furthermore, challenges with access to, affordability, and proper use of pharmaceuticals and laboratory materials can have devastating consequences on diagnosis and treatment.

The key to ending TB is to work together to strengthen health systems in high TB-burden countries to be able to effectively implement both proven and innovative strategies. Four approaches will help save lives by uniting stakeholders to collaborate, innovate, and end TB:

 {Photo credit: MSH Ethiopia}Atsede Tefera recalls three months of long delays in the diagnosis of tuberculosis for her daughter Nigist, who was eventually able to initiate treatment.Photo credit: MSH Ethiopia

When my daughter got sick, I took her to a clinic in my neighborhood. They gave her cough syrup for seven days.

I thought she was getting better, but it was apparent that she was still ill. After another examination, they referred her to St. Paul Hospital in Addis Ababa where they put her on oxygen and started taking blood sample after sample and injection after injection for a month. Her condition did not get better so they gave her another medicine. The doctors then decided to take blood from her back… only then did they know it was tuberculosis.

~ Atsede Tefera

Tuberculosis (TB) kills more people each year than any other infectious disease, causing over 1.5 million deaths globally. More than a quarter of cases are in Africa, the region with the highest burden of TB disease relative to population. Children are amongst the most vulnerable, and all too often children with TB remain in the shadows, undiagnosed, uncounted, and untreated. Today, more than 53 million children worldwide are infected with TB and over 400 die each day from this preventable and curable disease. 

Pages

Printer Friendly Version